A C Lerario
Overview
Explore the profile of A C Lerario including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tavares C, Rassi C, Fahel M, Wajchenberg B, Rochitte C, Lerario A
Int J Cardiovasc Imaging
. 2016 Jul;
32(10):1577-85.
PMID: 27432440
Evaluate whether glycemic control in type 2 diabetes (DM2) asymptomatic for coronary artery disease (CAD) affects not only the presence and magnitude of CAD but also the characteristics of plaque...
2.
Bosco A, Lerario A, Santos R, Wajchenberg B
Diabetologia
. 2003 Nov;
46(12):1669-75.
PMID: 14598030
Aims/hypothesis: Our aim was to compare the therapeutic effect of thalidomide and rosiglitazone on the prevention of diabetic retinopathy in streptozotocin-induced diabetic rats. Methods: Male Holtzman rats of 6 to...
3.
Lottenberg S, Giannella-Neto D, Derendorf H, Rocha M, Bosco A, Carvalho S, et al.
Int J Clin Pharmacol Ther
. 1998 Oct;
36(9):501-5.
PMID: 9760012
Objective: Patients with predominantly upper body obesity are at greater risk for developing diabetes mellitus, hyperlipidemia, hypertension, and cardiovascular disease. Little is known about the mechanisms involved in the regulation...
4.
Lerario A, Bosco A, Rocha M, Santomauro A, LUTHOLD W, Giannella D, et al.
Diabetes Metab
. 1997 Feb;
23(1):68-74.
PMID: 9059769
Possible associations between increased visceral fat component and serum lipid concentrations, glucose tolerance and insulinaemia (specific radioimmunoassay) were studied as risk factors for cardiovascular disease in 50 adult obese women...
5.
Salgado L, Semer M, Nery M, Knoepfelmacher M, Lerario A, Povoa G, et al.
J Endocrinol Invest
. 1996 Jul;
19(7):433-40.
PMID: 8884537
Growth hormone (GH) secretion disorders have been reported in poorly controlled type I diabetes mellitus patients. Our work was aimed to evaluate GH secretion in 9 type I young diabetes...
6.
Cattalini M, Lerario A
Rev Assoc Med Bras (1992)
. 1996 Apr;
42(2):109-14.
PMID: 9110460
No abstract available.
7.
Wajchenberg B, Bosco A, Marone M, Levin S, Rocha M, Lerario A, et al.
J Clin Endocrinol Metab
. 1995 Sep;
80(9):2791-4.
PMID: 7673425
Body composition determined by dual energy x-ray absorptiometry and the abdominal visceral fat component determined by computed tomographic scanning were examined in women with Cushing's disease and compared with those...
8.
Lerario A, Netto D, Wajchenberg B
Metabolism
. 1995 Jul;
44(7):923-8.
PMID: 7616852
Insulin-like growth factor-I (IGF-I) receptors are characterized in several animal and human tissues. IGF-I receptor studies performed in erythrocytes to assess IGF-I receptor status at target-cell tissues are potentially useful...
9.
Marcondes J, Minanni S, Luthold W, Lerario A, Nery M, Mendonca B, et al.
J Endocrinol Invest
. 1995 Jun;
18(6):431-5.
PMID: 7594237
This study explored the effect of the anti-androgen spironolactone on sex-hormone binding globulin (SHBG) and the distribution of circulating testosterone (T) into various free and bound fractions in seven women...
10.
Knoepfelmacher M, Villares S, NICOLAU W, Germek O, Lerario A, Wajchenberg B, et al.
Horm Metab Res
. 1994 Oct;
26(10):481-5.
PMID: 7851873
The effects of the intravenous administration of a calcium channel blocker, verapamil (0.0833 mg/min for 2-3 h after a 5 mg bolus) on prolactin (PRL) and thyrotropin (TSH) circulating levels...